POSSIBLE CAUSES OF STEROID RESISTANCE IN ACANTHOLYSIS BULLOSA AND WAYS OF ITS PREVENTION
- Authors: Teplyuk N.1, Dukhanin A.2, Potekayev N.1, Kochergin N.1, Kupriyanova A.3
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- N.I. Pirogov Russian National Research Medical University, Moscow
- V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
- Issue: Vol 24, No 2 (2013)
- Pages: 68-74
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115703
- ID: 115703
Cite item
Open Access
Access granted
Abstract
Some patients with acantholysis bullosa are resistant to monotherapy with systemic glucocorticoids. The latter have been found to have none or weak calcium-blocking effects in patients with steroid resistance. There were no significant changes in inositol triphosphate levels in the group of patients with steroid resistance. Clinical criteria for steroid resistance and ways of its prevention have been developed.
Full Text
About the authors
N. Teplyuk
I.M. Sechenov First Moscow State Medical University
Email: morenero@mail.ru
A. Dukhanin
N.I. Pirogov Russian National Research Medical University, Moscow
Email: morenero@mail.ru
N. Potekayev
I.M. Sechenov First Moscow State Medical University
Email: morenero@mail.ru
N. Kochergin
I.M. Sechenov First Moscow State Medical University
Email: morenero@mail.ru
A. Kupriyanova
V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Email: morenero@mail.ru
References
- Белоусов Ю.Б., Духанин А.С., Лукьянов С.В. и др. Пуриновые и глюкокортикоидные рецепторы у детей с бронхиальной астмой и хроническими бронхолегочными заболеваниями, сопровождающимися бронхообструктивным синдромом // Пульмонология. - 1999; 2: 30-5.
- Европейское руководство по лечению дерматологических болезней. Ruocco V., Brenner S., Ruocco E. Пузырчатка вульгарная. Под ред. Кацамбаса А.Д., Лотти Т.М. / М.: МЕДпресс-информ. - 2009; 409-21.
- Орлов С., Кальмодулин Н. Итоги науки и техники (сер. «Общие проблемы физико-химической биологии»). - 1987; 8.
- Сергеев П.В., Галенко-Ярошевский П.А., Ханкоева А.И. и др. Изучение механизма действия бефола на кальциевый обмен в кардиомиоцитах с помощью флуоресцентного зонда ФУРА-2 // Бюл. Экспер. Биол. - 1996; 3: 288-91.
- Суздальцева И.В., Копытова Т.В., Пантелеева Г.А. и др. Фосфолипидный спектр плазмы крови и мембран эритроцитов у больных акантолитической пузырчаткой // Совр. пробл. дерматовенерол., иммунол. и врачебной косметол. - 2009; 3 (06): 14-9.
- De la Fuente H., Baranda A., Hernandes M. et al. Lack of involvement of P-glycoprotein (P-gp) in pemphigus patients with poor response to steroid therapy // J. Dermatol. Sci. - 2002; 28 (3): 219-26.
- Dos Reis V., Cuce L., Rivittin E. Anatomopatology and direct and indirect immunofluorescence of lesions of endemic pemphigus foliaceus resistent to corticoid therapy // Rev. Inst. Med. Trop. Sao Pulo. - 1991; 33 (2): 97-103.
- Goebeler M., Herzog S., Brocker E. et al. Rapid response of treatment-resistant pemphigus foliaceus to the anti-CD20 antibody rituximab // Br. J. Dermatol. - 2003; 149: 899-901.
- Joly P., D'Incan M., Musette P. Rituximab for pemphigus vulgaris // N. Engl. J. Med. - 2007; 356 (5): 521-2.
- Kino T., De Martino M., Charmandari E. et al. Tissue glucocorticoid resistancehypersensitivity syndromes // J. Steroid. Biochem. Mol. Biol. - 2003; 85 (2-5): 457-67.
- Korman M. New and emerging therapies in the treatment a blistering diseases // Dermatol. Clinics. - 2000; 18: 127-37.
- Nambiar M., Enyedy E., Fisher C. et al. Dexametasone modulates TCR zeta chain expression and antigen receptor-mediated early signaling events in human T-lymphocytes // Cell. Immunol. - 2001; 208 (1): 62-71.
- Savin J. The events leading to death of patients with pemphigus and pemphigoid // Br. J. Dermatol. - 1979; 101: 521-34.
- Van der Velden V. Glucocorticoids: mechsnisms of action and antiinflammatory potential in asthma // Mediators Inflamm. - 1998; 7 (4): 229-37.
Supplementary files
